arrow
J

John J.V. McMurray

university of glasgow
H指数:231
被引数:35.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sudden Death in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction: A Pooled Analysis of Five Randomized Trials

心力衰竭患者中轻度降低或保留射血分数的突然死亡:五项随机试验的合并分析

2026-11-060
PRE
Dose–Exposure–Response Analysis of Finerenone on Serum Potassium and Cardiovascular Outcomes Among Patients With Heart Failure: Insights From FINEARTS ‐ HF

富马酸非布利酮剂量-暴露-反应分析:在心衰患者血清钾和心血管结局中的应用——来自FINEARTS-HF研究的启示

2026-11-030
OAAI
2026-08-300
OAAI
Personalized evaluation of NT-proBNP and clinical characteristics in suspected heart failure: the PRECISE-HF study

疑似心力衰竭患者中NT-proBNP和临床特征的个性化评估:PRECISE-HF研究

2026-08-280
OAAI
Low-Normal Hemoglobin Concentrations and Clinical Outcomes in Heart Failure

低正常血红蛋白浓度与心力衰竭的临床结局

2026-08-280
PRE
Finerenone benefits in patients with cardio-kidney-metabolic syndrome with or without history of cancer: the FINE-HEART pooled analysis

在有无癌症病史的心肾代谢综合征患者中非奈利酮的获益:FINE-HEART合并分析

2026-08-180
OAAI
Sleep Apnea in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

心力衰竭伴轻度降低或保留射血分数时的睡眠呼吸暂停

2026-06-230
PRE
A Randomized Clinical Implementation Trial Testing a Digital Strategy to Increase SGLT2 Inhibitor Initiation in Heart Failure

随机临床实施试验:测试一种数字策略以增加心力衰竭患者SGLT2抑制剂起始使用

2026-06-110
PRE
REPLY

请提供需要翻译的内容。

2026-06-010
PRE
Optimal serum potassium concentrations in heart failure: an individual patient data meta-analysis

心力衰竭患者的最佳血清钾浓度:一项个体患者数据Meta分析

2026-05-280
PRE